VF
RVNC

Virtu Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History

Virtu Financial’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23,129
Closed -$120K – 2219
2024
Q3 		$120K Buy
+23,129
New +$115K 0.01% 876
2024
Q1 		– Sell
-24,946
Closed -$219K – 2252
2023
Q4 		$219K Sell
24,946
-11,431
-31% -$93.7K 0.02% 764
2023
Q3 		$417K Buy
36,377
+23,788
+189% +$457K 0.04% 396
2023
Q2 		$319K Buy
+12,589
New +$392K 0.02% 590
2020
Q4 		– Sell
-27,010
Closed -$679K – 1870
2020
Q3 		$679K Buy
+27,010
New +$708K 0.12% 205

Other funds holding RVNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Virtu Financial's RVNC Position: Q4 2024 in Review

Virtu Financial sold out of Revance Therapeutics, Inc. (RVNC) in Q4 2024, closing a stake of 23,129 shares — an estimated $120K sold.

Virtu Financial first reported a position in RVNC in Q3 2020 and held it in 5 quarters. The position peaked at $679K in Q3 2020. 173 funds tracked by Wall St. Rank hold RVNC as of Q4 2024.

  • Virtu Financial reported no remaining Revance Therapeutics, Inc. position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 23,129 Revance Therapeutics, Inc. shares in Q4 2024, an estimated $120K.
  • Virtu Financial first reported a position in Revance Therapeutics, Inc. in Q3 2020 and held it in 5 quarters.
  • Virtu Financial's Revance Therapeutics, Inc. position peaked at $679K in Q3 2020.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.